Skip to main content
Back
Watch Compare

Organogenesis Holdings Inc.

Data quality: 100%
ORGO
Nasdaq Manufacturing Chemicals
$2.30
▼ $0.10 (-3.97%)
Mkt Cap: 295.23 M
Price
$2.30
Mkt Cap
295.23 M
Day Range
$2.23 — $2.43
52-Week Range
$2.21 — $7.08
Volume
1,406,441
Open $2.40
50D / 200D Avg
$3.21
28.50% below
50D / 200D Avg
$4.27
46.22% below

Quick Summary

Key Takeaways

Revenue grew 4.78% annually over 5 years — modest growth
Earnings grew 4201.05% over the past year
ROE of 15.17% — decent returns on equity
Negative free cash flow of -24.46 M
P/E of 7.97 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 12.26%

Growth

Revenue Growth (5Y)
4.78%
Above sector avg (1.82%)
Revenue (1Y)17.04%
Earnings (1Y)4201.05%
FCF Growth (3Y)N/A

Quality

Return on Equity
15.17%
Above sector avg (-53.41%)
ROIC8.65%
Net Margin6.56%
Op. Margin7.92%

Safety

Debt / Equity
N/A
Current Ratio3.32
Interest Coverage19.59

Valuation

PE (TTM)
7.97
Above sector avg (-1.48)
P/B Ratio1.16
EV/EBITDA3.86
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E 8.0 -1.5
P/B 1.2 1.6
ROE % 15.2 -53.4
Net Margin % 6.6 -41.5
Rev Growth 5Y % 4.8 1.8
D/E — 0.3

ETFs Holding This Stock

EES logo EES WisdomTree U.S. SmallCap Fund
0.12% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.04% weight
AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.02% weight
LABU logo LABU Direxion Daily S&P Biotech Bull 3X ETF
0.02% weight
ISCB logo ISCB iShares Morningstar Small-Cap ETF
0.01% weight
IWV logo IWV iShares Russell 3000 ETF
0.00% weight
AVUS logo AVUS Avantis U.S. Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 17.04% Revenue Growth (3Y) 14.13%
Earnings Growth (1Y) 4201.05% Earnings Growth (3Y) 173.66%
Revenue Growth (5Y) 4.78% Earnings Growth (5Y) -20.96%
Profitability
Revenue (TTM) 564.17 M Net Income (TTM) 37.03 M
ROE 15.17% ROA 7.63%
Gross Margin N/A Operating Margin 7.92%
Net Margin 6.56% Free Cash Flow (TTM) -24.46 M
ROIC 8.65% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.32
Interest Coverage 19.59 Asset Turnover 1.16
Working Capital 209.43 M Tangible Book Value 216.41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 7.97 Forward P/E N/A
P/B Ratio 1.16 P/S Ratio 0.52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 3.86 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.29%
Market Cap 295.23 M Enterprise Value 231.49 M
Per Share
EPS (Diluted TTM) 0.15 Revenue / Share 4.39
FCF / Share -0.19 OCF / Share -0.08
EPS CAGR (1Y) N/A EPS CAGR (5Y) -32.20%
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2.51% FCF Conversion -66.05%
SBC-Adj. FCF -36.15 M Growth Momentum 12.26

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 564.17 M 482.04 M 433.14 M 450.89 M 468.06 M
Net Income 37.03 M 861,000.0 4.95 M 15.53 M 94.90 M
EPS (Diluted) 0.15 -0.01 0.04 0.12 0.71
Gross Profit — 366.30 M 326.66 M 345.87 M 353.86 M
Operating Income 44.69 M -1.28 M 12.53 M 22.30 M 72.92 M
EBITDA — — — — —
R&D Expenses 44.54 M 50.27 M 44.38 M 39.76 M 30.74 M
SG&A Expenses 326.24 M 294.51 M 269.75 M 283.81 M 250.20 M
D&A 15.27 M 13.62 M — — —
Interest Expense -2.28 M 1.54 M 2.19 M 2.01 M 7.24 M
Income Tax 9.94 M -3.67 M 5.45 M 4.75 M -31.12 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 598.73 M 497.89 M 460.03 M 449.36 M 443.26 M
Total Liabilities 164.81 M 112.57 M 181.36 M 183.69 M 201.22 M
Shareholders' Equity 300.13 M 262.90 M 278.66 M 265.67 M 242.04 M
Total Debt — — 66.56 M 71.25 M 74.06 M
Cash & Equivalents 93.68 M 135.57 M 103.84 M 102.48 M 113.93 M
Current Assets 362.19 M 285.94 M 225.04 M 222.61 M 226.98 M
Current Liabilities 100.12 M 77.48 M 80.51 M 75.02 M 82.01 M